These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3587271)

  • 21. Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia.
    Tukiainen E; Wikström J; Kilpeläinen H
    Med Biol; 1981 Apr; 59(2):116-20. PubMed ID: 6458746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serotonin distribution between plasma and platelets in clinically healthy children].
    Mello P; Stagni S; Gualandi S; Corsini F
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1062-7. PubMed ID: 7295391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duchenne muscular dystrophy: does serum myoglobin correlate with serum creatine kinase?
    Kiessling WR; Beckmann R
    Muscle Nerve; 1981; 4(3):257. PubMed ID: 7242564
    [No Abstract]   [Full Text] [Related]  

  • 26. Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans.
    Pietraszek MH; Choudhury NA; Baba S; Sakaguchi S; Hachiya T; Urano T; Takada Y; Takada A
    Int Angiol; 1993 Mar; 12(1):9-12. PubMed ID: 8376917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased water permeability of erythrocyte membranes in patients with Duchenne muscular dystrophy.
    Serbu AM; Marian A; Popescu O; Pop VI; Borza V; Benga I; Benga G
    Muscle Nerve; 1986; 9(3):243-7. PubMed ID: 3702912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of platelet glass bead adhesion and platelet membrane glycoprotein IV (CD36) in Duchenne muscular dystrophy.
    Maurin N; Forst J; Leithe H; Forst R
    Thromb Haemost; 1998 May; 79(5):1067. PubMed ID: 9609256
    [No Abstract]   [Full Text] [Related]  

  • 31. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy].
    Kashiwagi S; Akaike M; Kawai H; Adachi K; Saito S
    Rinsho Shinkeigaku; 1996 Jan; 36(1):7-11. PubMed ID: 8689797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
    Caranobe C; Sie P; Nouvel C; Laurent G; Pris J; Boneu B
    Scand J Haematol; 1980 Oct; 25(4):289-95. PubMed ID: 7209398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].
    Toifl K; Presterl E; Graninger W
    Wien Klin Wochenschr; 1991; 103(8):232-5. PubMed ID: 1907056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood platelet 5-hydroxytryptamine accumulation and migraine.
    Carroll JD; Coppen A; Swade CC; Wood KM
    Ups J Med Sci Suppl; 1980; 31():10-2. PubMed ID: 6935852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cadmium treatment in vitro on the uptake and release of [3H]serotonin by human blood platelets.
    Mukhopadhyay S; Mukhopadhyay S; Addya S; Bhattacharya DK; Chatterjee GC
    Indian J Biochem Biophys; 1989 Feb; 26(1):56-60. PubMed ID: 2777314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes.
    Sohar I; Laszlo A; Gaal K; Mechler F
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():277-9. PubMed ID: 3202967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.